Association of leukocyte telomere length with breast cancer RISK: Nested case-control findings from the Shanghai Women's Health Study

American Journal of Epidemiology

Volumn 177, Issue 7, 2013, Pages 617-624

  Qu, Shimian ^b   Wen, Wanqing ^b   Shu, Xiao Ou ^b   Chow, Wong Ho ^b   Xiang, Yong Bing ^b   Wu, Jie ^b   Ji, Bu Tian ^b   Rothman, Nathaniel ^b   Yang, Gong ^b   Cai, Qiuyin ^b   Gao, Yu Tang ^b   Zheng, Wei ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b NONE

Author keywords

biomarkers; breast cancer; epidemiology; genetic factors; telomere

Indexed keywords

BIOMARKER; CANCER; CHROMOSOME; EPIDEMIOLOGY; HEALTH RISK; LOGISTICS; PUBLIC HEALTH; REGRESSION ANALYSIS; WOMENS HEALTH;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHESIS; LEUKOCYTE; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RISK; STATISTICAL SIGNIFICANCE; TELOMERE SHORTENING; WOMEN'S HEALTH;

ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHINA; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; RISK FACTORS; SOCIOECONOMIC FACTORS; TELOMERE;

CHINA; SHANGHAI;

EID: 84875972408     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws291     Document Type: Article

References (28)

1. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6(8):611-622.
2. Stewart SA, Weinberg RA. Telomeres: cancer to human aging. Annu Rev Cell Dev Biol. 2006;22:531-557.
3. Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci U S A. 1998;95(1):90-92.
4. Mathon NF, Lloyd AC. Cell senescence and cancer. Nat Rev Cancer. 2001;1(3):203-213.
5. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A. 2004;101(49):17312-17315.
6. Oikawa S, Tada-Oikawa S, Kawanishi S. Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening. Biochemistry. 2001;40(15): 4763-4768.
7. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005; 366(9486):662-664.
8. von Zglinicki T . Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27(7):339-344.
9. Alter BP, Giri N, Savage SA, et al. Cancer in dyskeratosis congenita. Blood. 2009;113(26):6549-6557.
10. Bisoffi M, Heaphy CM, Griffith JK. Telomeres: prognostic markers for solid tumors. Int J Cancer. 2006;119(10): 2255-2260.
11. Ma H, Zhou Z, Wei S, et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS One. 2011;6:e20466.
12. Wentzensen IM, Mirabello L, Pfeiffer RM, et al. The association of telomere length and cancer: a metaanalysis. Cancer Epidemiol Biomarkers Prev. 2011;20(6): 1238-1250.
13. Levy T, Agoulnik I, Atkinson EN, et al. Telomere length in human white blood cells remains constant with age and is shorter in breast cancer patients. Anticancer Res. 1998; 18(3A):1345-1349.
14. Pooley KA, Sandhu MS, Tyrer J, et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res. 2010;70(8):3170-3176.
15. Svenson U, Nordfjall K, Stegmayr B, et al. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res. 2008;68(10):3618-3623.
16. Gramatges MM, Telli ML, Balise R, et al. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev. 2010;19(2):605-613.
17. Zheng YL, Ambrosone C, Byrne C, et al. Telomere length in blood cells and breast cancer risk: investigations in two casecontrol studies. Breast Cancer Res Treat. 2010;120(3): 769-775.
18. Shen J, Terry MB, Gurvich I, et al. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res. 2007; 67(11):5538-5544.
19. Shen J, Gammon MD, Terry MB, et al. Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer. 2009;124(7):1637-1643.
20. Barwell J, Pangon L, Georgiou A, et al. Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity? Br J Cancer. 2007;97(12): 1696-1700.
21. De Vivo I, Prescott J, Wong JY, et al. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(4): 1152-1156.
22. Zheng W, Chow WH, Yang G, et al. The Shanghai Women?s Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol. 2005;162(11):1123-1131.
23. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009;37(3):e21.
24. Harrell F. Regression Modeling Strategies. New York, NY: Springer; 2001.
25. Prescott J, Wentzensen IM, Savage SA, et al. Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res. 2011;730(1-2):75-84.
26. Schroder CP, Wisman GB, de JS, et al. Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer. 2001;84(10): 1348-1353.
27. Shen M, Cawthon R, Rothman N, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of lung cancer. Lung Cancer. 2011;73(2):133-137.
28. Lan Q, Cawthon R, Shen M, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res. 2009;15(23):7429-7433.